2025-11-17 • PR Newswire
Atossa Highlights Emerging Opportunity for (Z)-Endoxifen in Duchenne Muscular Dystrophy, Including Symptomatic Female Carriers, Following Peer-Reviewed Publication and Scientific Presentation
2025-11-17 • PR Newswire
Atossa Highlights Emerging Opportunity for (Z)-Endoxifen in Duchenne Muscular Dystrophy, Including Symptomatic Female Carriers, Following Peer-Reviewed Publication and Scientific Presentation2025-11-08 • musculardystrophynews.com
DMD drugs show promise despite trial’s missing main goal: Sarepta2025-11-07 • ad-hoc-news.de
Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure2025-11-07 • globenewswire.com
Solid Biosciences Awarded Innovation Passport Designation Under the New UK Innovative Licensing and Access Pathway for SGT-003, an Investigational Gene Therapy for Duchenne Muscular Dystrophy2025-11-06 • medcitynews.com
Despite Phase 3 Failure, Sarepta Still Sees Path for Muscle Disease Drugs to Secure Full FDA Approval2025-11-05 • clinicaltrialsarena.com
Two of Sarepta’s DMD drugs fail to meet primary endpoint in confirmatory trial8 hours ago • news.mongabay.com
Lesotho communities allege greenwashing by project transferring water to South Africa8 hours ago • timesofindia.indiatimes.com
SITEX 2025 to unveil cutting-edge textile tech8 hours ago • globalarbitrationreview.com
Kazakh mining investor brings ICSID claim against Guinea8 hours ago • independent.com.mt
MFSA strengthens Malta’s Islamic finance sector with new Shariah-Compliant Fund framework8 hours ago • bbc.com
Lottery funding supports new deaf charity project8 hours ago • fuelcellsworks.com
Stablegrid Group Selects ITM Power for 710 MW of Energy Infrastructure Projects in Germany8 hours ago • thestatesman.com
Ayush Ministry highlights India’s traditional healthcare legacy at Delhi Trade Fair8 hours ago • cbsnews.com
Renovations begin at Denver's Civic Center Park for the first time in 100 years9 hours ago • markets.financialcontent.com
Blue Lake Biotechnology to Resume Enrollment of RSV-negative Toddlers in Phase 1/2a Clinical Trial of BLB2019 hours ago • scanx.trade
Garg Furnace Reports Strong Q2 Performance with Focus on Value-Added Steel9 hours ago • unmannedsystemstechnology.com
Cutting-Edge Additive Manufacturing Technologies & Industrial 3D Printing Solutions for Drone & Robotics Components10 hours ago • klfy.com
Lafayette Drug Bust Finds 13k Cash Stolen Gun 170k In Drugs4 hours ago • EIN Presswire
Global Consulting Services Market Growth Outlook Strengthens Through 20333 hours ago • EIN Presswire
December Special: Free Vehicle Alignment With Any Service at 616 Auto Repair4 hours ago • PR Newswire
ModuleMD Showcases Advanced AI-Driven Allergy Solutions at ACAAI 202511 hours ago • armyrecognition.com
Russia’s Su-75 Stealth Fighter Jet Nears Bench Testing Milestone Ahead of First Flight Phase.14 hours ago • thebarentsobserver.com
New military hospital in Northern Russia opens doors for legions of wounded men2025-11-21 • defensemirror.com
UAC Delivers Improved Su-30SM2 Fighters to Russian Naval Aviation8 hours ago • timesofindia.indiatimes.com
SITEX 2025 to unveil cutting-edge textile tech8 hours ago • sentinelassam.com
Sarbananda Sonowal reviews Rs 1,000-crore water metro project across B’putra8 hours ago • fibre2fashion.com
Value shopping drives Indian festive retail, RAI reports 11% growth8 hours ago • bbc.com
Lottery funding supports new deaf charity project9 hours ago • proactiveinvestors.com
Ukog Raise More Funds As Hydrogen Project Move Forward9 hours ago • icr.ac.uk
First men invited to take part in the most ambitious prostate cancer trial in decadesStay ahead with real-time headlines from top sources, categorized by sector and country.